Article
- Author:
- Sy Atezaz Saeed, MD, MS
Publish date: October 1, 2023
Attention-deficit/hyperactivity disorder (ADHD) is a developmental disorder characterized by a persistent pattern of inattention, impulsivity, and/...
Article
- Author:
- Sy Atezaz Saeed, MD, MS
Publish date: June 30, 2023
COVID-19’s increased demand on the mental health care delivery system led to expanded utilization of technology-based solutions, including digital ...
Article
- Author:
- Sy Atezaz Saeed, MD, MS
Publish date: April 3, 2023
FIRST OF 2 PARTS
New evidence can help guide the use of stimulants, viloxazine, guanfacine, and brexpiprazole.
Article
- Author:
- Sy Atezaz Saeed, MD, MS
Publish date: December 22, 2022
Posttraumatic stress disorder (PTSD) is a chronic and disabling psychiatric disorder.
Article
- Author:
- Sy Atezaz Saeed, MD, MS
Publish date: October 3, 2022
F or patients with generalized anxiety disorder (GAD), the intensity, duration, and frequency of an individual’s anxiety and worry are out of propo...
Article
- Author:
- Sy Atezaz Saeed, MD, MS
Publish date: July 1, 2022
FIRST OF 2 PARTS: Evidence suggests several medications and rTMS may offer benefit.
Article
- Author:
- Sy Atezaz Saeed, MD, MS
Publish date: April 1, 2022
Obsessive-compulsive disorder (OCD) is a chronic, debilitating neuropsychiatric disorder that affects 1% to 3% of the population worldwide.1,2...
Article
- Author:
- Sy Atezaz Saeed, MD, MS
Publish date: February 1, 2022
Evidence suggests benefits from several forms of psychoeducation and psychotherapy.
Article
- Author:
- Sy Atezaz Saeed, MD, MS
Publish date: October 29, 2021
Borderline personality disorder (BPD) is marked by an ongoing pattern of mood instability, cognitive distortions, pro...
Article
- Author:
- Sy Atezaz Saeed, MD, MS
Publish date: May 3, 2021
Depressive episodes are part of DSM-5 criteria for bipolar II disorder, and are also often experienced by patients with bipolar I disorder.
Article
- Author:
- Sy Atezaz Saeed, MD, MS
Publish date: December 23, 2020
Evidence suggests some agents might help treat irritability and other symptoms associated with autism spectrum disorder.
Article
- Author:
- Sy Atezaz Saeed, MD, MS
Publish date: November 2, 2020
Initial research explores the toll on health care workers, patients, and the general public.
Article
- Author:
- Sy Atezaz Saeed, MD, MS
Publish date: September 1, 2020
Evidence suggests CBT-I might benefit patients with comorbid depression, sleep apnea, or PTSD.
Article
- Author:
- Sy Atezaz Saeed, MD, MS
Publish date: May 26, 2020
Some early research suggests CBD might be beneficial for patients with psychosis, but evidence is mixed.
Article
- Author:
- Sy Atezaz Saeed, MD, MS
Publish date: February 3, 2020
Second of 2 parts. These studies may change how you treat schizophrenia, MDD, alcohol use disorder, more.
